Strategic funding to accelerate cattle clinical studies for Ferizyme™ and prepare for human reproductive health applications.

战略性融资以加速 Ferizyme™ 的牛临床研究，并为人类生殖健康应用做好准备。

REHOVOT, Israel and NEW YORK

以色列雷霍沃特和纽约

,

，

July 30, 2026

2026年7月30日

/PRNewswire/ -- Mercantile Life Science Ventures IV (MLSV) and Big Idea Ventures (BIV), via its Generation Food Rural Partners fund (GFRP), today announced a joint investment in Maia Fertility. The biotechnology company is advancing reproductive health through its proprietary sustained-release enzyme platform, Ferizyme™..

/美通社/ -- Mercantile Life Science Ventures IV（MLSV）与Big Idea Ventures（BIV）通过其旗下的Generation Food Rural Partners基金（GFRP）今日宣布联合投资Maia Fertility。这家生物技术公司正凭借其专有的缓释酶平台Ferizyme™推动生殖健康领域的发展。

This funding will expand clinical studies across commercial cattle operations, providing the scientific foundation for future human medical applications.

这笔资金将扩大在商业化养牛场开展的临床研究，为未来的人类医学应用奠定科学基础。

Continue Reading

继续阅读

Maia Fertility's upcoming market

Maia Fertility 即将上市

A Partnership Built for Impact

为影响力而建立的合作伙伴关系

The partnership leverages MLSV's life sciences expertise and BIV's agricultural acceleration to:

该合作伙伴关系利用MLSV在生命科学领域的专业知识和BIV在农业加速方面的能力，以：

Advance Clinical Validation:

高级临床验证：

Complete efficacy studies on commercial farms in North America and Europe.

在北美和欧洲的商业农场开展完整的功效研究。

Optimize Technology:

优化技术：

Refine sustained-release delivery for maximum success rates.

优化缓释递送系统，以实现最高成功率。

Scale Markets:

规模市场：

Drive livestock industry adoption while preparing healthcare infrastructure.

在准备医疗保健基础设施的同时，推动畜牧业的采用。

Voices Behind the Investment

投资背后的声音

'Ferizyme™ represents a fundamental rethinking of fertility. With MLSV and BIV, we have the infrastructure to prove this technology at scale and carry that momentum into the market,' said Nir Arbel, CEO of Maia Fertility.

“Ferizyme™代表了对生育力的根本性重新思考。凭借MLSV和BIV，我们拥有大规模验证这项技术的基础设施，并将这一势头带入市场，”Maia Fertility首席执行官Nir Arbel表示。

'At Big Idea Ventures, we invest to support founders solving foundational challenges in the agriculture, food, and materials sectors. The science behind Ferizyme™ is compelling, the cattle market opportunity is immediate, and the long-term pathway into human reproductive health is transformative. We're excited to accelerate what Maia Fertility has built.'.

“在Big Idea Ventures，我们投资以支持那些解决农业、食品和材料领域基础挑战的创始人。Ferizyme™背后的科学令人信服，牛市场机会迫在眉睫，而进入人类生殖健康的长期路径具有变革性。我们很高兴能加速Maia Fertility所建立的一切。”

— Tom Mastrobuoni, Chief Investment Officer, Big Idea Ventures

— Tom Mastrobuoni，Big Idea Ventures 首席投资官

'Reproductive efficiency is key to both healthcare and agriculture. Mercantile is proud to bring this technology to the farms and clinics that need it most,' stated I. Steven Edelson, CEO of Mercantile Companies Inc.

“生殖效率对医疗保健和农业都至关重要。Mercantile 很自豪能将这项技术带给最需要的农场和诊所，”Mercantile Companies Inc. 首席执行官 I. Steven Edelson 表示。

About the Companies

关于公司

About Maia Fertility:

关于迈亚生育中心：

Dedicated to eliminating reproductive bottlenecks via Ferizyme™, a sustained-release enzyme improving fertility in mammals.

致力于通过Ferizyme™消除生殖瓶颈，这是一种能改善哺乳动物生育能力的缓释酶。

About Mercantile Companies Inc.

关于 Mercantile Companies Inc.

–

–

Headquartered in Chicago, IL, Mercantile companies inc. is a global investment firm with investments in the healthcare, wellness, agriculture and technology/AI sectors. The firm manages a diverse international portfolio, driving long-term value through operational expertise and strategic market expansion..

Mercantile Companies Inc. 总部位于伊利诺伊州芝加哥，是一家全球性投资公司，在医疗健康、大健康、农业以及科技/人工智能领域进行投资。该公司管理着多元化的国际投资组合，通过运营专业知识和战略性市场扩张推动长期价值增长。

About Big Idea Ventures –

关于 Big Idea Ventures –

BIV is a global investment firm focused on food, agriculture, and materials innovation, with more than 100 portfolio companies across 30 countries.

BIV 是一家全球性投资公司，专注于食品、农业和材料创新，在30个国家拥有100多家投资组合公司。

GFRP is an RBIC-licensed investment fund built by Big Idea Ventures to support economic growth and innovation in rural communities across the United States. The fund focuses on food, agriculture, and protein technologies, creating new companies from scientific discoveries and intellectual property developed by universities, research institutions, and industry partners.

GFRP 是一只由 Big Idea Ventures 设立并获得 RBIC 许可的投资基金，旨在支持美国农村地区的经济增长与创新。该基金专注于食品、农业和蛋白质技术领域，基于大学、研究机构和行业合作伙伴开发的科学发现及知识产权创立新公司。

GFRP operates through a venture-build model that identifies promising technologies and forms companies designed for rapid commercialization and industry adoption. The fund is backed by members of the Farm Credit System, including Farm Credit Services of America, CoBank, Compeer Financial, and Mid-America Farm Credit..

GFRP 采用风险企业构建模式，识别具有潜力的技术，并组建旨在实现快速商业化及行业应用的公司。该基金由美国农业信贷系统（Farm Credit System）的成员支持，包括美国农业信贷服务公司（Farm Credit Services of America）、CoBank、Compeer Financial 和 Mid-America Farm Credit。

Media Contact

媒体联系人

Nir Arbel

尼尔·阿贝尔

0545849213

0545849213

[email protected]

[email protected]

SOURCE Maia Fertility

来源：Maia 生育中心

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示